The clinical and immunohistochemical effect of UVA-1 phototherapy on discoid lupus erythematosus (DLE): a randomised controlled trial
| ISRCTN | ISRCTN31313147 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN31313147 |
| Secondary identifying numbers | N0436186543 |
- Submission date
- 28/09/2007
- Registration date
- 28/09/2007
- Last edited
- 03/02/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr David Fairhurst
Scientific
Scientific
Department of Dermatology
Dawson Floor
Brotherton Wing
Great George Street
Leeds
LS1 3EX
United Kingdom
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | The clinical and immunohistochemical effect of UVA-1 phototherapy on discoid lupus erythematosus (DLE): a randomised controlled trial |
| Study objectives | 1. To ascertain whether or not UVA-1 phototherapy improves DLE 2. To ascertain what immunohistochemical changes occur in DLE lesions following UVA-1 phototherapy |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Skin and Connective Tissue Diseases: Discoid lupus erythematosus (DLE) |
| Intervention | Phototherapy vs standard therapy |
| Intervention type | Procedure/Surgery |
| Primary outcome measure | 1. Improvement in DLE after UVA-1 phototherapy 2. Immunohistochemical changes following UVA-1 phototherapy |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/08/2006 |
| Completion date | 01/02/2008 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | Patients with DLE attending the Dermatology Department |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/08/2006 |
| Date of final enrolment | 01/02/2008 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Department of Dermatology
Leeds
LS1 3EX
United Kingdom
LS1 3EX
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government
Government
The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Phone | +44 (0)20 7307 2622 |
|---|---|
| dhmail@doh.gsi.org.uk | |
| Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Hospital/treatment centre
Leeds Teaching Hospitals NHS Trust (UK)
No information available
NHS R&D Support Funding
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
